Big data is revolutionising healthcare and it is at our fingertip! Find out how to get onboard the movement that is fast transforming the way we live and work!
Cancer Biomarkers in the Era of Personalised Medicines
Event Type
Section
Event Location
Event Description
The European Cancer Patient Coalition, together with MEP Marlene Mizzi (S&D, Malta), is organising an event on the topic of Cancer Biomarkers in the Era of Personalised Medicines.
During the event, expert speakers will discuss the vital role that of cancer biomarkers play in improving cancer care throughout Europe. The European Cancer Patient Coalition will also launch an animation and infographic on this topic. There will also be a call for action for increased access to biomarkers, while raising awareness on the topic and increasing patients’ understanding of where they need to go to access molecular profiling.
As you may know, cancer biomarkers can be detected in bodily fluids or tissues. They can identify people who have cancer or who are at risk of getting cancer. Cancer biomarkers can also help select those people who are most likely to derive therapeutic benefit from chemotherapy, immuno-oncology therapy, surgery, or radiotherapy. In fact, biomarkers are essential to identify the Achilles’ heel of the tumour that doctors can target with specific drugs. They can also be used to monitor remission in cancer survivors. In short, biomarkers help to identify the people who may benefit from different types of cancer treatment, ensure sustainable healthcare systems, and avoid treatment-related toxicity.
Register here!
Related Events
Ten years after the European Commission’s “White paper on a Strategy for Europe on Nutrition, Overweight and Obesity-related health issues”, the European Snacks Association gathers stakeholders to discuss the lessons learned and explore ways of building consensus on eff
There are currently over 200 million women living with diabetes and this total is projected to increase to more than 300 million by 2040. Diabetes is the ninth leading cause of death in women globally, causing 2.1 million deaths each year.
The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC a
Hosted by MEP Heinz K. Becker (EPP, Austria)
European Policy Response to Metastatic Breast Cancer
Tuesday 17th October 2017, 12.00-14.00 CET
Consumer rights
Sustainable agriculture, safer food, strong rural communities
At the European Parliament in Brussels in room A3G-3.
On Wednesday 27 September 2017 from 14h30 - 17h30.
On the 20th of June 2017, Brussels will become the capital of Flavour.
Skin Cancer: Safe Work Under the Sun
The European Parliament Interest Group on Allergy and Asthma invites you to the policy symposium “United Action for Allergy and Asthma” at the Europea
“European policy response to rare cancers: the case of sarcoma”
8th February 2017, 14h30-16h30
European Parliament, Altiero Spinelli building, room A5E-2, Brussels
Preventing sight loss in an ageing population
The role of screening and early diagnosis in identifying eye diseases as comorbidities of non-communicable diseases
Pages
Jobs
EURACTIV News
- Macron, Lula hail defense ties at submarine launch
- Migrant crossings to UK hit new record, heaping pressure on Sunak
- Commission on alert after unexpected changes in Greece’s EU-funded HPV testing
- Ireland to intervene in South Africa genocide case against Israel
- Putin says Russia will not attack NATO, but F-16s will be shot down in Ukraine